Jonathan C. Javitt

Insider Reports History

Entity
Individual
Location
1201 North Market Street, Suite 111, Wilmington, DE
Signature
/s/ Jonathan C. Javitt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan C. Javitt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. Chief Scientist, Director, 10%+ Owner Common Stock 12.6M $4.03M $0.32 Aug 23, 2023 By the Jonathan Javitt Living Trust
NRX Pharmaceuticals, Inc. Chief Scientist, Director, 10%+ Owner Common Stock 1.42M $455K $0.32 Aug 23, 2023 By the Javitt 2012 Irrevocable Dynasty Trust
NRX Pharmaceuticals, Inc. Chief Scientist, Director, 10%+ Owner Common Stock 446K $143K $0.32 Aug 23, 2023 Direct
NRX Pharmaceuticals, Inc. Chief Scientist, Director, 10%+ Owner Common Stock 300K $96K $0.32 Aug 23, 2023 By the Jonathan Javitt Donor Advised Fund

Insider Reports Filed by Jonathan C. Javitt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRXP NRX Pharmaceuticals, Inc. Aug 23, 2023 1 $33K 4 Aug 24, 2023 Chief Scientist, Director, 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Aug 22, 2023 1 $64.4K 4 Aug 23, 2023 Chief Scientist, Director, 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Dec 31, 2022 1 $0 5 Feb 14, 2023 Director, 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Dec 7, 2022 1 -$400K 4 Dec 9, 2022 Director, 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. Jun 1, 2022 1 $58K 4/A Jun 2, 2022 Chief Scientist, Director, 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 3 $0 4 Jun 10, 2021 Chief Executive Officer, Director, 10%+ Owner
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 0 $0 3 Jun 10, 2021 Chief Executive Officer, Director, 10%+ Owner